XML 84 R63.htm IDEA: XBRL DOCUMENT
v3.22.4

Share-Based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share-based Compensation Expenses | The share-based compensation expense included in the determination of net earnings was:
Years ended December 31, |  | 2022 |  |  | 2021 |
Equity settled share-based payments |  | $ | 1,558 |  |  | $ | 1,783 |
Deferred share units |  |  | 3,622 |  |  |  | 3,053 |
Phantom share entitlement plan |  |  | 117 |  |  |  | 102 |
Performance share units |  |  | 4,172 |  |  |  | 3,470 |
Restricted share units |  |  | 4,454 |  |  |  | 2,751 |
Cash performance target |  |  | 2,239 |  |  |  | 1,778 |
Share-based compensation expense |  | $ | 16,162 |  |  | $ | 12,937 |
Summary of Equity-Settled Share-Based Payments |
(b) | Equity-Settled Share-Based Payments
|  | 2022 |  |  | 2021 |
Years ended December 31, |  | Number of options |  |  | Weighted average exercise price |  |  | Number of options |  |  | Weighted average exercise price |
Options outstanding, beginning of period |  |  | 4,456,444 |  |  | $ | 11.66 |  |  |  | 4,057,142 |  |  | $ | 12.78 |
Granted |  |  | - |  |  |  | - |  |  |  | 654,847 |  |  |  | 7.85 |
Exercised 1 |  |  | (47,120) |  |  |  | 5.51 |  |  |  | - |  |  |  | - |
Forfeited |  |  | (27,286) |  |  |  | 13.51 |  |  |  | (24,267) |  |  |  | 9.25 |
Expired |  |  | (1,292,809) |  |  |  | 13.98 |  |  |  | (231,278) |  |  |  | 20.75 |
Options outstanding, end of period |  |  | 3,089,229 |  |  | $ | 10.77 |  |  |  | 4,456,444 |  |  | $ | 11.66 |
Options exercisable, end of period |  |  | 1,671,421 |  |  | $ | 12.48 |  |  |  | 2,445,230 |  |  | $ | 13.62 |
1 The weighted average share price of options at the date of exercise for the year ended December 31, 2022 was $8.03 (December 31, 2021 – nil).
Summary of Options Outstanding and Exercisable | The following table summarizes options outstanding and exercisable at December 31, 2022:
|  | Options Outstanding Options Exercisable |
Range of exercise prices |  | Number outstanding |  |  | Weighted average remaining life (years) |  |  | Weighted average exercise price |  |  | Number outstanding |  |  | Weighted average remaining life (years) |  |  | Weighted average exercise price |
$5.51 – $6.68 |  |  | 783,880 |  |  |  | 4.62 |  |  | $ | 5.51 |  |  |  | 286,552 |  |  |  | 4.62 |  |  | $ | 5.51 |
$6.69 – $13.51 |  |  | 1,072,991 |  |  |  | 4.30 |  |  |  | 9.81 |  |  |  | 460,251 |  |  |  | 2.95 |  |  |  | 11.48 |
$13.52 – $16.12 |  |  | 1,232,358 |  |  |  | 2.86 |  |  |  | 14.95 |  |  |  | 924,618 |  |  |  | 2.70 |  |  |  | 15.14 |
Total |  |  | 3,089,229 |  |  |  | 3.81 |  |  | $ | 10.77 |  |  |  | 1,671,421 |  |  |  | 3.10 |  |  | $ | 12.48 |
Deferred share units [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
|  | Number of DSUs |  |  | Weighted average grant date fair value per unit |
DSUs outstanding, January 1, 2022 |  |  | 1,406,170 |  |  | $ | 10.51 |
Granted |  |  | 307,037 |  |  |  | 7.12 |
In lieu of dividends |  |  | 20,806 |  |  |  | 6.86 |
Vested |  |  | (108,500) |  |  |  | 5.45 |
DSUs outstanding, December 31, 2022 |  |  | 1,625,513 |  |  | $ | 10.16 |
Phantom Share Entitlement Plan [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
|  | Number of PSEs |  |  | Weighted average grant date fair value per unit |
PSEs outstanding, January 1, 2022 |  |  | 222,920 |  |  | $ | 12.15 |
Expired |  |  | (22,669) |  |  |  | 11.69 |
PSEs outstanding, December 31, 2022 |  |  | 200,251 |  |  | $ | 12.21 |
Performance share units [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
|  | Number of PSUs |  |  | Weighted average grant date fair value per unit |
PSUs outstanding, January 1, 2022 |  |  | 1,308,416 |  |  | $ | 9.02 |
Granted |  |  | 634,382 |  |  |  | 6.29 |
In lieu of dividends |  |  | 17,835 |  |  |  | 6.93 |
Vested |  |  | (318,887) |  |  |  | 6.10 |
PSUs outstanding, December 31, 2022 |  |  | 1,641,746 |  |  | $ | 8.51 |
Restricted share units [member] |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
Summary of Share Units |
|  | Number of RSUs |  |  | Weighted average grant date fair value per unit |
RSUs outstanding, January 1, 2022 |  |  | 896,474 |  |  | $ | 7.62 |
Granted |  |  | 995,336 |  |  |  | 6.29 |
Acquisition (Note 7) |  |  | 572,260 |  |  |  | 6.29 |
In lieu of dividends |  |  | 11,344 |  |  |  | 6.98 |
Vested |  |  | (394,537) |  |  |  | 6.15 |
Forfeited |  |  | (79,044) |  |  |  | 6.73 |
RSUs outstanding, December 31, 2022 |  |  | 2,001,833 |  |  | $ | 6.90 |

X
- Definition Disclosure details of share based compensation expenses explanatory. + References No definition available. + Details
Name: | efxt_DisclosureDetailsOfShareBasedCompensationExpensesExplanatory
Namespace Prefix: | efxt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=efxt_DeferredShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=efxt_PhantomShareEntitlementPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=efxt_PerformanceShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=efxt_RestrictedShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |